drugset / Trial / NCT06393400
CHemotherapy and Stool Transplant in PDAC (CHASe-PDAC)
NaSingle-groupOpen-labelTreatment
Summary
To confirm the safety of combining oral fecal microbiota transplantation (FMT) with gemcitabine and nab-paclitaxel chemotherapy as first line treatment in patients with unresectable or metastatic pancreatic ductal adenocarcinoma.
Timeline
- Start
- 2025-01-08
- Primary completion
- 2028-02
- Completion
- 2028-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 125 mg/m2 | Intravenous |
| Background | polyethylene glycol | Other / unclassified | 17 g | Oral |